Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Dominici

Showing results (21-30 of 309) with videos related to

Pageof 31
Sort By:
Tumori|October 26, 2021
Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case reportStefania Pipitone, Maria Giuseppa Vitale, Cinzia Baldessari, et al.
Tumori|September 4, 2020
PD-1 blockade in deficient mismatch repair mixed adenoneuroendocrine carcinoma of the stomach: new hope for an orphan diseaseBeatrice Riccò, Massimiliano Salati, Luca Reggiani Bonetti, et al.
The Journal of Biological Chemistry|March 7, 2006
Trophoblast stem cells rescue placental defect in SOCS3-deficient miceYutaka Takahashi, Massimo Dominici, John Swift, et al.
Stem Cells International|April 17, 2014
Mesenchymal stem cell biodistribution, migration, and homing in vivoWeian Zhao, Donald G Phinney, Dominique Bonnet, et al.
Lancet (London, England)|October 5, 2024
New WHO INN for cell-based and gene-based substances: timing, usage, and simplicityTony Manderson, Ursula Loizides, Massimo Dominici, et al.
The Oncologist|June 28, 2014
Rare breast cancer subtypes: histological, molecular, and clinical peculiaritiesMaria Vittoria Dieci, Enrico Orvieto, Massimo Dominici, et al.
Cancer Letters|June 5, 2012
Sarcomas as a mise en abyme of mesenchymal stem cells: exploiting interrelationships for cell mediated anticancer therapyJorge S Burns, Akmal Safwat, Giulia Grisendi, et al.
Cytotherapy|January 1, 2018
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparationsFederica Boraldi, Jorge S Burns, Angelica Bartolomeo, et al.
Tumori|December 5, 2023
Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case reportMarta Venturelli, Stefano Greco, Cinzia Baldessari, et al.
Blood|July 21, 2010
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cellsFriederike Gieseke, Judith Böhringer, Rita Bussolari, et al.
Pageof 31

Showing results (21-30 of 309) with videos related to

Sort By:
Pageof 31
Tumori|October 26, 2021
Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case reportStefania Pipitone, Maria Giuseppa Vitale, Cinzia Baldessari, et al.
Tumori|September 4, 2020
PD-1 blockade in deficient mismatch repair mixed adenoneuroendocrine carcinoma of the stomach: new hope for an orphan diseaseBeatrice Riccò, Massimiliano Salati, Luca Reggiani Bonetti, et al.
The Journal of Biological Chemistry|March 7, 2006
Trophoblast stem cells rescue placental defect in SOCS3-deficient miceYutaka Takahashi, Massimo Dominici, John Swift, et al.
Stem Cells International|April 17, 2014
Mesenchymal stem cell biodistribution, migration, and homing in vivoWeian Zhao, Donald G Phinney, Dominique Bonnet, et al.
Lancet (London, England)|October 5, 2024
New WHO INN for cell-based and gene-based substances: timing, usage, and simplicityTony Manderson, Ursula Loizides, Massimo Dominici, et al.
The Oncologist|June 28, 2014
Rare breast cancer subtypes: histological, molecular, and clinical peculiaritiesMaria Vittoria Dieci, Enrico Orvieto, Massimo Dominici, et al.
Cancer Letters|June 5, 2012
Sarcomas as a mise en abyme of mesenchymal stem cells: exploiting interrelationships for cell mediated anticancer therapyJorge S Burns, Akmal Safwat, Giulia Grisendi, et al.
Cytotherapy|January 1, 2018
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparationsFederica Boraldi, Jorge S Burns, Angelica Bartolomeo, et al.
Tumori|December 5, 2023
Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case reportMarta Venturelli, Stefano Greco, Cinzia Baldessari, et al.
Blood|July 21, 2010
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cellsFriederike Gieseke, Judith Böhringer, Rita Bussolari, et al.
Pageof 31